Becton Dickinson & Co. said its profit and revenue rose for the fiscal third quarter as healthcare utilization levels continued to recover from the initial effects of the Covid-19 pandemic.
The Franklin Lakes, N.J.-based medical-technology company on Thursday posted net income of $525 million, compared with $286 million a year earlier. Earnings were $1.72 a share, compared with 97 cents a share.
Adjusted earnings were $2.74 a share. Analysis polled by FactSet were expecting $2.45 a share.
Revenue rose 26.9% to $4.89 billion, the company said. Analysts were looking for $4.51 billion.
Covid-19 testing revenue was $300 million, including BD Veritor Plus System revenue of $212 million, the company said.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.